Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Personalized Medicine and Pharmacogenomics"
A special issue of Pharmaceutics (ISSN 1999-4923).
Deadline for manuscript submissions: closed (15 September 2016).
Dr. Huixiao Hong
National Center for Toxicological Research, U.S. Food and Drug Administration , 3900 NCTR Road, Building 5, Room 5C-109A, Jefferson, AR 72079, USA
Interests: pharmacogenomics; personalized medicine; toxicogenomics; bioinformatics; predictive toxicology
Special Issues and Collections in MDPI journals
Personalized medicine enhance healthcare by selecting treatments that are more efficient or induce less adverse responses in stratified cohorts with different genetic content. Pharmacogenomics is the key to identify personalized medicine biomarkers useful for efficacy and safety that can ultimately be clinically applied for diagnosis and prognosis and treatment selection. This Special Issue, “Personalized Medicine and Pharmacogenomics”, will deal with all aspects of personalized medicine and pharmacogenomics. The topics of papers in this Special Issue include genetics, genomics, proteomics and metabolomics biomarkers, emerging techniques, such as next-generation sequencing, diagnosis and prognosis of diseases, applications in drug development, and regulatory sciences. In addition, papers dealing with bio-banks, intellectual property rights, human subject issues, such as patient privacy and confidentiality in implementing personalized medicine, will also be considered.
Dr. Huixiao Hong
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- personalized medicine
- regulatory sciences
- drug development